AG
ONC

Advisor Group’s BeOne Medicines Ltd ONC Stock Holding History

Advisor Group’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$60K Buy
365
+17
+5% +$2.83K ﹤0.01% 3307
2019
Q3 		$43K Buy
348
+51
+17% +$6.77K ﹤0.01% 3509
2019
Q2 		$37K Sell
297
-7
-2% -$888 ﹤0.01% 3570
2019
Q1 		$40K Buy
304
+19
+7% +$2.56K ﹤0.01% 3539
2018
Q4 		$40K Buy
285
+214
+301% +$28.4K ﹤0.01% 3349
2018
Q3 		$12K Buy
71
+63
+788% +$10.6K ﹤0.01% 4200
2018
Q2 		$1K Sell
8
-43
-84% -$7.67K ﹤0.01% 4845
2018
Q1 		$8K Sell
51
-49
-49% -$6.64K ﹤0.01% 4226
2017
Q4 		$10K Hold
100
– – ﹤0.01% 4102
2017
Q3 		$10K Buy
+100
New +$7.45K ﹤0.01% 3985

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return

Advisor Group's ONC Position: Q4 2019 in Review

Advisor Group increased its BeOne Medicines Ltd (ONC) stake by 4.9% in Q4 2019, buying an estimated $2.83K and bringing the position to 365 shares worth $60K. The position accounts for ﹤0.01% of the portfolio, ranked #3307.

Advisor Group first reported a position in ONC in Q3 2017 and has held it in 10 quarters since. 221 funds tracked by Wall St. Rank hold ONC as of Q4 2019.

  • Advisor Group held 365 shares of BeOne Medicines Ltd worth $60K as of Q4 2019.
  • Advisor Group bought 17 BeOne Medicines Ltd shares in Q4 2019, an estimated $2.83K.
  • BeOne Medicines Ltd made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #3307 holding.
  • Advisor Group first reported a position in BeOne Medicines Ltd in Q3 2017 and has held it in 10 quarters since.
  • 221 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.